Crane (CR - Get Report) was upgraded to neutral from underperform at Bank of America/Merrill Lynch. $70 price target. The company continues to execute well, despite weak market fundamentals, analysts said.
Dow Chemical (DOW) was upgraded to overweight from neutral at JPMorgan. $60 price target. The company is cutting costs and can continue to drive growth following its merger with DuPont, JPMorgan said.
MicroStrategy (MSTR - Get Report) was downgraded to market perform from outperform at JMP Securities. The company missed consensus expectations, with licensing down 20% and operating income down 30% from the previous year, JMP said.
Myriad Genetics (MYGN - Get Report) was downgraded to underperform from neutral at Bank of America/Merrill Lynch. $25 price target. Pricing pressures will begin to erode earnings growth, analysts said.
Western Digital (WDC - Get Report) was upgraded to outperform from neutral at Robert Baird. $65 price target. The company is leveraged to stronger NAND flash, HDD pricing and PC demand trends, Robert Baird said.